174 related articles for article (PubMed ID: 38170500)
1. Genetic Risk Factors for Early-Onset Merkel Cell Carcinoma.
Mohsin N; Hunt D; Yan J; Jabbour AJ; Nghiem P; Choi J; Zhang Y; Freeman AF; Bergerson JRE; Dell'Orso S; Lachance K; Kulikauskas R; Collado L; Cao W; Lack J; Similuk M; Seifert BA; Ghosh R; Walkiewicz MA; Brownell I
JAMA Dermatol; 2024 Feb; 160(2):172-178. PubMed ID: 38170500
[TBL] [Abstract][Full Text] [Related]
2. BRCA1/2 Pathogenic Variants Are Not Common in Merkel Cell Carcinoma: Comprehensive Molecular Study of 30 Cases and Meta-Analysis of the Literature.
Gaubert A; Kervarrec T; Montaudié H; Burel-Vandenbos F; Cardot-Leccia N; Di Mauro I; Fabas T; Tallet A; Kubiniek V; Pedeutour F; Dadone-Montaudié B
J Invest Dermatol; 2023 Jul; 143(7):1178-1186. PubMed ID: 36754117
[TBL] [Abstract][Full Text] [Related]
3. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
4. Genomic Alterations and Tumor Mutation Burden in Merkel Cell Carcinoma.
Brazel D; Kumar P; Doan H; Pan T; Shen W; Gao L; Moyers JT
JAMA Netw Open; 2023 Jan; 6(1):e2249674. PubMed ID: 36602798
[TBL] [Abstract][Full Text] [Related]
5. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS
JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444
[TBL] [Abstract][Full Text] [Related]
6. Molecular Profiling of Multiple Primary Merkel Cell Carcinoma to Distinguish Genetically Distinct Tumors From Clonally Related Metastases.
Harms KL; Lazo de la Vega L; Hovelson DH; Rahrig S; Cani AK; Liu CJ; Fullen DR; Wang M; Andea AA; Bichakjian CK; Johnson TM; Tomlins SA; Harms PW
JAMA Dermatol; 2017 Jun; 153(6):505-512. PubMed ID: 28403382
[TBL] [Abstract][Full Text] [Related]
7. Correlation of Merkel cell polyomavirus positivity with PDGFRα mutations and survivin expression in Merkel cell carcinoma.
Batinica M; Akgül B; Silling S; Mauch C; Zigrino P
J Dermatol Sci; 2015 Jul; 79(1):43-9. PubMed ID: 25936870
[TBL] [Abstract][Full Text] [Related]
8. Danger is only skin deep: aggressive epidermal carcinomas. An overview of the diagnosis, demographics, molecular-genetics, staging, prognostic biomarkers, and therapeutic advances in Merkel cell carcinoma.
Tetzlaff MT; Harms PW
Mod Pathol; 2020 Jan; 33(Suppl 1):42-55. PubMed ID: 31676786
[TBL] [Abstract][Full Text] [Related]
9. Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma.
Van Gele M; Leonard JH; Van Roy N; Cook AL; De Paepe A; Speleman F
Int J Cancer; 2001 May; 92(3):409-13. PubMed ID: 11291079
[TBL] [Abstract][Full Text] [Related]
10. Gene-expression profiling reveals distinct expression patterns for Classic versus Variant Merkel cell phenotypes and new classifier genes to distinguish Merkel cell from small-cell lung carcinoma.
Van Gele M; Boyle GM; Cook AL; Vandesompele J; Boonefaes T; Rottiers P; Van Roy N; De Paepe A; Parsons PG; Leonard JH; Speleman F
Oncogene; 2004 Apr; 23(15):2732-42. PubMed ID: 14755241
[TBL] [Abstract][Full Text] [Related]
11. Second cancers following the diagnosis of Merkel cell carcinoma: a nationwide cohort study.
Koljonen V; Kukko H; Tukiainen E; Böhling T; Sankila R; Joensuu H; Pukkala E
Cancer Epidemiol; 2010 Feb; 34(1):62-5. PubMed ID: 20061203
[TBL] [Abstract][Full Text] [Related]
12. Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.
Goh G; Walradt T; Markarov V; Blom A; Riaz N; Doumani R; Stafstrom K; Moshiri A; Yelistratova L; Levinsohn J; Chan TA; Nghiem P; Lifton RP; Choi J
Oncotarget; 2016 Jan; 7(3):3403-15. PubMed ID: 26655088
[TBL] [Abstract][Full Text] [Related]
13. Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer.
Truong H; Breen K; Nandakumar S; Sjoberg DD; Kemel Y; Mehta N; Lenis AT; Reisz PA; Carruthers J; Benfante N; Joseph V; Khurram A; Gopalan A; Fine SW; Reuter VE; Vickers AJ; Birsoy O; Liu Y; Walsh M; Latham A; Mandelker D; Stadler ZK; Pietzak E; Ehdaie B; Touijer KA; Laudone VP; Slovin SF; Autio KA; Danila DC; Rathkopf DE; Eastham JA; Chen Y; Morris MJ; Offit K; Solit DB; Scher HI; Abida W; Robson ME; Carlo MI
Eur Urol; 2023 Jan; 83(1):29-38. PubMed ID: 36115772
[TBL] [Abstract][Full Text] [Related]
14. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of P73 and TP53 in Merkel cell carcinoma.
Van Gele M; Kaghad M; Leonard JH; Van Roy N; Naeyaert JM; Geerts ML; Van Belle S; Cocquyt V; Bridge J; Sciot R; De Wolf-Peeters C; De Paepe A; Caput D; Speleman F
Br J Cancer; 2000 Feb; 82(4):823-6. PubMed ID: 10732753
[TBL] [Abstract][Full Text] [Related]
16. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
17. Joint occurrence of Merkel cell carcinoma and non-Hodgkin lymphomas in four Nordic countries.
Koljonen V; Rantanen M; Sahi H; Mellemkjær L; Hansen BT; Chen T; Hemminki K; Pukkala E
Leuk Lymphoma; 2015; 56(12):3315-9. PubMed ID: 25899400
[TBL] [Abstract][Full Text] [Related]
18. The first observation of the association of Merkel cell polyomavirus and Merkel cell carcinoma in Brazil.
Neto CF; Oliveira WRP; Costa PVA; Cardoso MK; Barreto PG; Romano CM; Urbano PR
Int J Dermatol; 2019 Jun; 58(6):703-706. PubMed ID: 30620056
[TBL] [Abstract][Full Text] [Related]
19. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J
BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698
[TBL] [Abstract][Full Text] [Related]
20. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
Lee DS; Yoon SY; Looi LM; Kang P; Kang IN; Sivanandan K; Ariffin H; Thong MK; Chin KF; Mohd Taib NA; Yip CH; Teo SH
Breast Cancer Res; 2012 Apr; 14(2):R66. PubMed ID: 22507745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
